Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...

Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors ...

The concept of using Mycobacterium for cancer treatment goes back to the 19th Century. Today, bacillus Calmette–Guerin (BCG) vaccine is a well-established treatment for human bladder cancer that ...

为解决膀胱癌治疗中 BCG 疗效不佳的问题，石河子大学医学院的研究人员开展了 Mcl-1 下调联合 BCG 治疗膀胱癌的研究。结果显示该联合治疗可促进巨噬细胞极化，提升疗效。这为膀胱癌治疗提供新思路，强烈推荐科研读者阅读。

Due to the ongoing shortage of BCG, gemcitabine has been increasingly used for first-line NMIBC therapy. N-803’s ability to activate natural killer and CD8+ T cells, thus the innate immune system, to ...

The following is a summary of “Comparison of treatments for preventing lower urinary tract symptoms after BCG immunotherapy of bladder tumors : a systematic review and network meta-analysis,” ...

therapy for patients with BCG-unresponsive nonmuscle-invasive bladder cancer (NMIBC) (1 Trusted Source Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with ...

Exploratory outcome measures include health-related quality of life, overall survival, and biomarker assessments. A broad cross-section of geographically and socioeconomically diverse clinical sites ...

First real-world outcomes data for ADSTILADRIN® (nadofaragene firadenovec-vncg) to be presented at 2025 ASCO Genitourinary ...

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

People are also enquiring whether cancer will be a disease of the past like polio or measles after the vaccine is available ...